Har­vard re­searchers call on Con­gress to clean up phar­ma com­pa­nies' mess of re­stric­tions on con­tract phar­ma­cies un­der 340B

The ex­plo­sion of phar­ma com­pa­nies re­strict­ing sales to cer­tain con­tract phar­ma­cies un­der a sub­si­dized drug pro­gram for low-in­come Amer­i­cans, along with a mix of court …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA